Previous 10 | Next 10 |
LOVELAND, Colo. , May 2, 2019 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA) (News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, announced that members of Heska's executive team will be presenting at the following upcoming conferences i...
LOVELAND, Colo. , April 16, 2019 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, plans to report its first quarter 2019 financial results in a press release on Tuesday, May 7, 201...
LOVELAND, Colo. , April 11, 2019 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, announced its 2019 Annual Meeting of Stockholders. The meeting is scheduled for 9 a.m. MT / 11...
LOVELAND, Colo. , March 8, 2019 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, announced that Mark Furlong has joined the Company's Board of Directors (the "Board"). M...
LOVELAND, Colo. , Feb. 27, 2019 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, announced that Kevin Wilson , Heska's President & Chief Executive Officer will be presenting at the ...
Heska (NASDAQ: HSKA ) downgraded to Hold at Benchmark. More news on: Heska Corporation, Karyopharm Therapeutics Inc., Mylan Inc, Healthcare stocks news, Stocks on the move, , Read more ...
Heska Corporation (HSKA) Q4 2018 Earnings Conference Call February 26, 2019 11:00 AM ET Company Participants Jon Aagaard – Director-Investor Relations Catherine Grassman – Chief Accounting Officer Kevin Wilson – Chief Executive Officer and President Jason N...
Heska ( HSKA ) Q4 results : Revenues: $34.1M (-5.3%); Core companion animal health: $28.3M (-4.7%); Other vaccines, pharmaceuticals and products: $5.8M (-7.9%). More news on: Heska Corporation, Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...
Heska (NASDAQ: HSKA ): Q4 Non-GAAP EPS of $0.46 misses by $0.30 ; GAAP EPS of $0.44 misses by $0.32 . More news on: Heska Corporation, Earnings news and commentary, Healthcare stocks news, Read more ...
LOVELAND, Colo. , Feb. 26, 2019 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, today reported financial results for its fourth quarter and full year ended December 31, 2018 . The Comp...
News, Short Squeeze, Breakout and More Instantly...
eXp World Holdings & Privia Health Group Set to Join S&P SmallCap 600 eXp World Holdings & Privia Health Group Set to Join S&P SmallCap 600 PR Newswire NEW YORK , June 7, 2023 /PRNewswire/ -- S&P Dow Jones Indices will make the follow...
NEW YORK, NY / ACCESSWIRE / May 11, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Midwest Holding Inc. (NASDAQ:MDWT)'s ...
NEW YORK, NY / ACCESSWIRE / April 28, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Hoth Therapeutics, Inc. (NASDAQ:HOTH...